Optimization of Neoadjuvant Therapy for Early-Stage Triple-Negative and HER2 + Breast Cancer

被引:0
|
作者
Sneha Phadke
机构
[1] University of Iowa Carver College of Medicine,Department of Internal Medicine, Holden Comprehensive Cancer Center
来源
Current Oncology Reports | 2022年 / 24卷
关键词
Breast cancer; Triple negative; HER2; Neoadjuvant therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1779 / 1789
页数:10
相关论文
共 50 条
  • [1] Optimization of Neoadjuvant Therapy for Early-Stage Triple-Negative and HER2+Breast Cancer
    Phadke, Sneha
    [J]. CURRENT ONCOLOGY REPORTS, 2022, 24 (12) : 1779 - 1789
  • [2] Neoadjuvant therapy in patients with triple negative and HER2 positive early breast cancer
    Harbeck, N.
    [J]. BREAST, 2017, 32 : S18 - S18
  • [3] Prospect of neoadjuvant/adjuvant immunotherapy in early-stage triple-negative breast cancer
    Hao, Xiaopeng
    Gao, Xianqi
    Yin, Shanshan
    Jiang, Zefei
    [J]. TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
  • [4] Recurrent Early-Stage Triple-Negative Breast Cancer
    Adonizio, Christian S.
    Grano, Genorosa
    Sharon, Kanu
    Rose, Lewis
    Zibelli, Allison
    Miller-Samuel, Susan
    Morris, Gloria J.
    [J]. SEMINARS IN ONCOLOGY, 2010, 37 (05) : 419 - 428
  • [5] TILs in early-stage triple-negative breast cancer
    Artemyeva, A.
    Chuglova, D.
    Kushnarev, V.
    Paltuev, R.
    Demina, N.
    Kudaybergenova, A.
    [J]. VIRCHOWS ARCHIV, 2019, 475 : S67 - S67
  • [6] MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
    Mustafa Kahraman
    Anne Röske
    Thomas Laufer
    Tobias Fehlmann
    Christina Backes
    Fabian Kern
    Jochen Kohlhaas
    Hannah Schrörs
    Anna Saiz
    Cassandra Zabler
    Nicole Ludwig
    Peter A. Fasching
    Reiner Strick
    Matthias Rübner
    Matthias W. Beckmann
    Eckart Meese
    Andreas Keller
    Michael G. Schrauder
    [J]. Scientific Reports, 8
  • [7] MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
    Kahraman, Mustafa
    Roeske, Anne
    Laufer, Thomas
    Fehlmann, Tobias
    Backes, Christina
    Kern, Fabian
    Kohlhaas, Jochen
    Schroers, Hannah
    Saiz, Anna
    Zabler, Cassandra
    Ludwig, Nicole
    Fasching, Peter A.
    Strick, Reiner
    Ruebner, Matthias
    Beckmann, Matthias W.
    Meese, Eckart
    Keller, Andreas
    Schrauder, Michael G.
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [8] De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+ and Triple-Negative Breast Cancer
    Lorena Gonzalez
    Joanne Mortimer
    Laura Kruper
    [J]. Current Breast Cancer Reports, 2021, 13 : 151 - 156
  • [9] De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+and Triple-Negative Breast Cancer
    Gonzalez, Lorena
    Mortimer, Joanne
    Kruper, Laura
    [J]. CURRENT BREAST CANCER REPORTS, 2021, 13 (03) : 151 - 156
  • [10] Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer
    Domergue, Camille
    Martin, Elodie
    Lemarie, Camille
    Jezequel, Pascal
    Frenel, Jean-Sebastien
    Augereau, Paule
    Campone, Mario
    Patsouris, Anne
    [J]. CANCERS, 2022, 14 (10)